✦ LIBER ✦

Safety of Liver Resection for Hepatocellular Carcinoma After Sorafenib Therapy: A Multicenter Case-Matched Study

✍ Scribed by Barbier, Louise; Fuks, David; Pessaux, Patrick; Muscari, Fabrice; Treut, Yves-Patrice; Faivre, Sandrine; Belghiti, Jacques

Book ID: 120987528
Publisher: Springer
Year: 2013
Tongue: English
Weight: 250 KB
Volume: 20
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-013-3029-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Field-practice study of sorafenib therap

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

✍ Massimo Iavarone; Giuseppe Cabibbo; Fabio Piscaglia; Claudio Zavaglia; Antonio G 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

on behalf of the SOFIA (SOraFenib Italian Assessment) study group A multicenter randomized controlled trial established sorafenib as a standard of care for patients with advanced hepatocellular carcinoma (HCC). Because the study was prematurely interrupted due to survival benefits in the sorafenib a

Sorafenib for hepatocellular carcinoma p

Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study

✍ Chieh-Lin Teng, Wen-Li Hwang, Yi-Ju Chen, Kuang-Hsi Chang, Shao-Bin Cheng 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 373 KB

Efficacy and Safety of Combination Thera

Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation

✍ De Simone, P.; Crocetti, L.; Pezzati, D.; Bargellini, I.; Ghinolfi, D.; Carrai, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Risk factors for early death due to recu

Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: Results of a multicenter study

✍ Jean Marc Regimbeau; Eddie K. Abdalla; Jean Nicolas Vauthey; Gregory Y. Lauwers; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

Safe use of sorafenib in a patient under

Safe use of sorafenib in a patient undergoing salvage liver transplantation for recurrent hepatocellular carcinoma after hepatic resection

✍ Richard Kim; Narayanan Menon; Federico Aucejo 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 260 KB

Laparoscopic vs. Open Liver Resection fo

Laparoscopic vs. Open Liver Resection for Hepatocellular Carcinoma of Cirrhotic Liver: A Case–Control Study

✍ Memeo, Riccardo; de’Angelis, Nicola; Compagnon, Philippe; Salloum, Chady; Cherqu 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 453 KB